CIFR
Cipher Mining Inc.
There isn't enough reported data to score CIFR yet.
HIPO
Hippo Holdings Inc.
HIPO's fundamentals are mixed, but it looks expensive: trading at 29x earnings, about four times its usual 7.7x. Its downside scenario is about seven times its upside.
CIFR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| N/A | |
| N/A |
CIFR's revenue and profitability are currently weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like CIFR.
HIPO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| N/A | |
| N/A |
HIPO's revenue is currently strong, and its profitability is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like HIPO.
CIFR PE Valuation
CIFR has no meaningful PE right now: it lost money over the past year.
HIPO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.3x | $8.14 | -78% |
| Fair | 7.7x | $9.87 | -73% |
| Expensive | 11x | $14.71 | -60% |
| Forward | 23x | $36.96 | — |
| Current | 29x | $36.96 | — |
Historical ranges are pointers, not guarantees.
HIPO's PE is in its expensive range at 29x. If earnings grow as analysts expect, today's price would be 23x next year's earnings.
CIFR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CIFR's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HIPO Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect HIPO to return to profit, with revenue growing.
CIFR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.06 | -$2.86 |
| Q2 2026 | -$2.85 | -$2.40 |
| Q1 2026 | -$2.32 | -$1.94 |
| Q4 2025 | -$2.15 | -$2.01 |
| Q3 2025 | -$0.20 | -$0.07 |
| Q2 2025 | -$0.45 | -850% |
| Q1 2025 | -$0.38 | -733% |
| Q4 2024 | -$0.14 | -$0.04 |
CIFR lost $3.06 per share over the past year, and its loss has widened in each of the last four quarters.
HIPO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.58 | +23% |
| Q3 2026 | $1.29 | -65% |
| Q2 2026 | $4.73 | +$5.12 |
| Q1 2026 | $4.40 | +$6.48 |
| Q4 2025 | $2.22 | +$3.86 |
| Q3 2025 | $3.72 | +$8.89 |
| Q2 2025 | -$0.39 | +$6.68 |
| Q1 2025 | -$2.08 | +$7.96 |
| Q4 2024 | -$1.64 | +$9.94 |
HIPO has the edge over CIFR on earnings quality, reporting a profit while its opponent remains loss making.
CIFR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $26.7M | -63% |
| Q2 2026 | $24.8M | -43% |
| Q1 2026 | $34.8M | -29% |
| Q4 2025 | $59.7M | +41% |
| Q3 2025 | $71.7M | +198% |
| Q2 2025 | $43.6M | +18% |
| Q1 2025 | $49M | +1.7% |
| Q4 2024 | $42.2M | -2.8% |
CIFR's revenue has slid since its 2025 peak: $27M last quarter, down 63% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -269% | -217 points |
| Q2 2026 | -316% | -212 points |
| Q1 2026 | -329% | -251 points |
| Q4 2025 | -503% | -544 points |
| Q3 2025 | -52% | +327 points |
| Q2 2025 | -104% | -60 points |
| Q1 2025 | -78% | -175 points |
| Q4 2024 | 40% | +4 points |
CIFR's operating margin was −269% last quarter, down 217 points from the same quarter a year ago.
HIPO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $156M | +29% |
| Q2 2026 | $144.7M | +23% |
| Q1 2026 | $121.5M | +10% |
| Q4 2025 | $120.4M | +18% |
| Q3 2025 | $120.6M | +26% |
| Q2 2025 | $117.3M | +31% |
| Q1 2025 | $110.3M | +30% |
| Q4 2024 | $101.9M | +58% |
HIPO has the edge over CIFR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.7% | -76 points |
| Q2 2026 | 7.6% | +4.2 points |
| Q1 2026 | 5.9% | +47 points |
| Q4 2025 | 5.7% | -41 points |
| Q3 2025 | 81% | +87 points |
| Q2 2025 | 3.4% | +44 points |
| Q1 2025 | -41% | -2.7 points |
| Q4 2024 | 46% | +107 points |
HIPO has the edge over CIFR on profitability, with a higher operating margin.
CIFR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.7B | -$1.4B |
| Q2 2026 | -$653.8M | -$566.3M |
| Q1 2026 | -$462.5M | -$390.7M |
| Q4 2025 | -$280.3M | -$204.2M |
| Q3 2025 | -$256.2M | -$173.1M |
| Q2 2025 | -$87.5M | -$54.3M |
| Q1 2025 | -$71.8M | -$37.3M |
| Q4 2024 | -$76.1M | +$38M |
CIFR's free cash flow was −$3.1B over the past year, against −$492M the year before. Free cash flow isn't a meaningful measure for financial services companies like CIFR.
HIPO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $72.2M | +330% |
| Q2 2026 | $43M | +73% |
| Q1 2026 | $8.4M | +$44.1M |
| Q4 2025 | $3.2M | +$9.7M |
| Q2 2025 | $24.8M | +$35.5M |
| Q1 2025 | -$35.7M | -303% |
| Q4 2024 | -$6.5M | +$42.4M |
| Q2 2024 | -$10.7M | +$27.6M |
HIPO has the edge over CIFR on cash generation, producing positive trailing cash flow while its opponent burns cash.
CIFR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.4% | +30.3M shares |
| 1 year | +12% | +46.5M shares |
| 3 years | +75% | +188M shares |
| 5 years | +102% | +222M shares |
CIFR has 440M diluted shares, up 12% from a year ago, despite $151M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7M |
| Q2 2026 | $45.2M |
| Q1 2026 | $3.8M |
| Q4 2025 | $82.3M |
| Q3 2025 | $3M |
| Q2 2025 | $3.2M |
| Q1 2025 | $1.1M |
| Q4 2024 | $16.9M |
CIFR spent $151M buying back its own shares over the past year, about six times what it spent the year before.
HIPO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +478K shares |
| 1 year | +3.9% | +1M shares |
| 3 years | +14% | +3.3M shares |
| 5 years | +21% | +4.7M shares |
| Available history | +5479% | +26.5M shares |
HIPO has the edge over CIFR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q4 2024 | $15.6M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | $1.6M |
| Q1 2023 | $200,000 |
CIFR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -2.3x | Net Cash |
| Q1 2025 | 125.4x | High |
| Q4 2024 | 0.5x | Very low |
| Q3 2024 | -0.7x | Net Cash |
| Q2 2024 | -1.2x | Net Cash |
| Q1 2024 | -0.9x | Net Cash |
| Q4 2023 | -2.2x | Net Cash |
| Q2 2023 | -0.1x | Net Cash |
CIFR has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like CIFR.
HIPO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | -8.7x | Net Cash |
HIPO has the edge over CIFR on leverage, with a lower net debt burden relative to earnings.
CIFR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.4 | Neutral |
| Stochastic | 7.8 | Oversold |
CIFR's weekly RSI is 34 (neutral) and its Stochastic is 8 (oversold).
HIPO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.3 | Neutral |
| Stochastic | 68.3 | Neutral |
HIPO's weekly RSI is 63 (neutral) and its Stochastic is 68 (neutral).
CIFR PE vs Financial Services Sector
| Metric | CIFR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
CIFR has no meaningful PE right now: it lost money over the past year.
HIPO PE vs Financial Services Sector
| Metric | HIPO | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 13x | 120% above |
| PE % | 100 | 62 | 38 pts above |
HIPO is trading at 29x earnings, a 120% premium to the Financial Services sector's median of 13x.
CIFR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.6 | 33% below |
| 20 week MA | $15.5 | 54% below |
| 50 week MA | $17.0 | 58% below |
| 100 week MA | $12.2 | 41% below |
| 200 week MA | $7.86 | 9% below |
CIFR is in a downtrend: it's below all five of its weekly moving averages, and 9% below its 200-week average.
HIPO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.9 | 6% above |
| 20 week MA | $32.7 | 13% above |
| 50 week MA | $29.9 | 24% above |
| 100 week MA | $29.4 | 26% above |
| 200 week MA | $22.6 | 63% above |
HIPO has the edge over CIFR on trend strength, trading above more of its moving averages.
CIFR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.92 | $9.95 | +0.3% |
| 2021 | $9.95 | $5.21 | -48% |
| 2022 | $5.21 | $0.54 | -90% |
| 2023 | $0.54 | $4.13 | +665% |
| 2024 | $4.13 | $4.86 | +18% |
| 2025 | $4.86 | $15.2 | +213% |
| 2026 YTD | $15.2 | $7.15 | -53% |
CIFR's yearly returns have swung widely, from +665% in 2023 to −90% in 2022. It's down 53% so far in 2026.
HIPO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $296.3 | $77.3 | -74% |
| 2022 | $77.3 | $12.1 | -84% |
| 2023 | $12.1 | $9.12 | -25% |
| 2024 | $9.12 | $27.4 | +200% |
| 2025 | $27.4 | $31.3 | +14% |
| 2026 YTD | $31.3 | $37.0 | +18% |
HIPO has the edge over CIFR on returns for 2026, with the stronger performance.